Page 3 - Nicolas Kressmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nicolas kressmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nicolas Kressmann Today - Breaking & Trending Today

Sanofi : MenQuadfi® demonstrates superior immune response against serogroup C meningococcal disease in toddlers


MenQuadfi® demonstrates superior immune response against serogroup C meningococcal disease in toddlers
Phase 3 study met primary and secondary endpoints demonstrating MenQuadfi® induced superior immune responses to serogroup C compared to a standard-of-care vaccine in healthy toddlers
MenQuadfi is the first and only quadrivalent ACWY vaccine to demonstrate superior immune response against serogroup C in toddlers
July 10, 2021
Results from a head-to-head Phase 3 study, evaluating the immune response of MenQuadfi® to serogroup C, one of the main serogroups of invasive meningococcal disease (IMD), compared to Nimenrix® (quadrivalent ACWY vaccine) and NeisVac-C® (monovalent C vaccine) in healthy toddlers, were presented today in an oral session at the 2021 European Congress of Clinical Microbiology and Infectious Disease. ....

United States , France General , United Kingdom , Eva Schaefer Jansen , Arnaud Delepine , Nicolas Kressmann , Suzanne Greco , Felix Lauscher , Markus Knuf , Fara Berkowitz , Sanofi Pasteur , Nathalie Pham , European Congress , Head Of Department , World Health Organization , European Commission , Drug Administration , European Centre For Disease Prevention , Media Update , Clinical Microbiology , Adolescent Medicine , Worms Clinic , Global Medical Head , Private Securities Litigation Reform Act , Statement Regarding Forward Looking , European Centre ,